BACKGROUND: Kidney transplantation is the preferred treatment for patients with end-stage renal disease, significantly preserving kidney function and patient quality of life. However, post-transplant diabetes mellitus (PTDM) is a common complication, occurring in approximately one-third of renal transplant recipients. This study aims to evaluate the role of pulse wave parameters in predicting PTDM and to identify other pre-transplant risk factors. METHODS: This prospective cohort study included 105 patients on the kidney transplant waiting list from 2017 to 2022. Exclusion criteria included any pre-existing diabetes mellitus. Patients underwent physical examinations, laboratory analyses, and pulse wave analysis before transplantation and one year post-transplant. PTDM diagnosis followed International Consensus Guidelines. Data were analyzed using Wilcox test, Bonferroni correction, May-Whitney U-test, and Fisher's exact test, with p < 0.05 considered statistically significant. RESULTS: Post-transplant, 21% of patients were diagnosed with PTDM, increasing to 35% 3months post-transplant and 43% at one year post-transplant. Significant findings included: Pre-transplat risk factors for developing PTDM: Proteinuria (p = 0.037, OR = 3.942) and perioperative hyperglycemia (p = 0.003, OR = 4.219 at 3 months; p = 0.001, OR = 4.571 at 1 year). Pulse wave parameters for developing PTDM: Pre-transplant Aortic PP > 45 mmHg (AUC = 0.757) and PWV > 8.5 m/s (AUC = 0.730) were strong predictors of the development of PTDM after 3 months (p < 0.0001). Moreover, we found significant improvements in aortic pulse pressure (Aortic PP) and pulse wave velocity (PWV) post-transplant (p < 0.0001). CONCLUSION: Our study confirms that pulse wave parameters, such as Aortic PP and PWV, are significant predictors of PTDM in kidney transplant recipients (KTR). These findings support incorporating pulse wave analysis into routine pre-transplant evaluations to identify high-risk patients. Additionally, monitoring these parameters post-transplant may aid in early intervention and prevention of PTDM, ultimately improving patient outcomes. TRIAL REGISTRATION: Ethical approval was obtained from the Ethics Committee of Medical faculty and University Hospital Olomouc (approval no. 94/15).

3rd Department of Internal Medicine University Hospital Olomouc Olomouc Czech Republic

Department of Clinical Biochemistry University Hospital Olomouc Olomouc Czech Republic

Department of Medical Biophysics Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic

See more in PubMed

Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transpl. 2003;3:2. PubMed

Chadban S. New-onset diabetes after transplantation should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients. Nephrol Dial Transpl. 2008;23:6. PubMed

Sharif A, Chakkera H, de Vries APJ, Eller K, Guthoff M, Haller MC, Hornum M, Nordheim E, Kautzky-Willer A, Krebs M, Kukla A, Kurnikowski A, Schwaiger E, Montero N, Pascual J, Jenssen TG, Porrini E, Hecking M. International consensus on post-transplantation diabetes mellitus. Nephrol Dialysis Transplantation. 2024. 10.1093/ndt/gfad258. PubMed PMC

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes Mellitus. Diabetes Care. 2003; 26(Suppl. 1). PubMed

Sharma J, Kapoor A, Muthu R, et al. Assessment of endothelial dysfunction in Asian Indian patients with chronic kidney disease and changes following renal transplantation. Clin Transpl. 2014. 10.1111/ctr.12398. PubMed

Prenner SB, Chirinos JA. Arterial stiffness in diabetes mellitus. Atherosclerosis. 2015; 238. PubMed

Opazo Saez A, Kos M, Witzke O, et al. Effect of new-onset diabetes mellitus on arterial stiffness in renal transplantation. Transpl Int. 2008. 10.1111/j.1432-2277.2008.00702.x. PubMed

Heleniak Z, Illersperger S, Małgorzewicz S et al. Arterial stiffness as a cardiovascular risk factor after successful kidney transplantation in diabetic and nondiabetic patients. Transplant Proc. 2022; 10.1016/j.transproceed.2022.07.007 PubMed

Borda B, Lázár G, Kormányos Á, et al. New-onset diabetes Mellitus following successful kidney transplantation facilitates aortic stiffening. Transpl Proc. 2019. 10.1016/j.transproceed.2019.04.009. PubMed

Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006; 27. PubMed

Gajdova J, Karasek D, Goldmannova D, Krystynik O, Schovanek J, Vaverkova H, Zadrazil J. Pulse wave analysis and diabetes mellitus. A systematic review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017; 161. PubMed

Ducloux D, Kazory A, Chalopin J-M. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study. Transplantation. 2005. 10.1097/01.TP.0000151799.98612.EB. PubMed

Conte C, Secchi A. Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention. Acta Diabetol. 2018. 10.1007/s00592-018-1137-8. PubMed

Eide IA, Halden TAS, Hartmann A, Dahle DO, Åsberg A, Jenssen T. Associations between posttransplantation diabetes mellitus and renal graft survival. Transplantation. 2017. 10.1097/TP.0000000000001259. PubMed

Sumrani NB, Delaney V, Ding ZK, Davis R, Daskalakis P, Friedman EA, Butt KM, Hong JH. Diabetes mellitus after renal transplantation in the cyclosporine era–an analysis of risk factors. Transplantation. 1991. 10.1097/00007890-199102000-00014. PubMed

Fernández-Fresnedo G, Escallada R, de Francisco AL, Rodrigo E, Zubimendi JA, Ruiz JC, Piñera C, Herraez I, Arias M. Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients. Transplant Proc. 2003; 10.1016/s0041-1345(03)00052-6 PubMed

Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol. 2005. 10.1681/ASN.2004070580. PubMed

Miles AM, Sumrani N, Horowitz R, Homel P, Maursky V, Markell MS, Distant DA, Hong JH, Sommer BG, Friedman EA. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation. 1998. 10.1097/00007890-199802150-00014. PubMed

Cheng CY, Chen CH, Wu MF, Wu MJ, Chen JP, Liu YM, Hou YC, Wang HY. Risk factors in and long-term survival of patients with post-transplantation diabetes mellitus: a retrospective cohort study. Int J Environ Res Public Health. 2020. 10.3390/ijerph17124581. PubMed PMC

Markell M. Clinical impact of posttransplant diabetes mellitus. Transpl Proc. 2001. 10.1016/s0041-1345(01)02230-8. PubMed

Jenssen T, Hartmann A. Post-transplant diabetes mellitus in patients with solid organ transplants. Nat Rev Endocrinol. 2019;15:3. PubMed

Cheddani L, Haymann JP, Liabeuf S, Tabibzadeh N, Boffa JJ, Letavernier E, Essig M, Drüeke TB, Delahousse M, Massy ZA, NephroTest Study Group. Less arterial stiffness in kidney transplant recipients than chronic kidney disease patients matched for renal function. Clin Kidney J. 2020. 10.1093/ckj/sfaa120. PMID: 34094521; PMCID: PMC8173621. PubMed PMC

Nagaraja P, Ravindran V, Morris-Stiff G, Baboolal K. Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation. Transpl Int. 2013. 10.1111/tri.12026. PubMed

Roland M, Gatault P, Al-Najjar A, Doute C, Barbet C, Chatelet V, Laouad I, Marlière JF, Nivet H, Büchler M, Lebranchu Y, Halimi JM. Early pulse pressure and low-grade proteinuria as independent long-term risk factors for new-onset diabetes mellitus after kidney transplantation. Am J Transpl. 2008;8:8. PubMed

Okumi M, Unagami K, Hirai T, Shimizu T, Ishida H, Tanabe K. Diabetes mellitus after kidney transplantation in Japanese patients: the Japan Academic Consortium of kidney transplantation study. Int J Urol. 2017. 10.1111/iju.13253. PubMed

Paek JH, Kang SS, Park WY, Jin K, Park SB, Han S, Kim CD, Ro H, Lee S, Jung CW, et al. Incidence of post-transplantation diabetes mellitus within 1 year after kidney transplantation and related factors in Korean cohort study. Transpl Proc. 2019. 10.1016/j.transproceed.2019.02.054. PubMed

Sinangil A, Celik V, Barlas S, Koc Y, Basturk T, Sakaci T, Akin EB, Ecder T. The incidence of new onset diabetes after transplantation and related factors: single center experience. Nefrologia. 2017. 10.1016/j.nefro.2016.11.022. PubMed

Walczak DA, Calvert D, Jarzembowski TM, Testa G, Sankary HN, Thielke J, et al. Increased risk of post-transplant diabetes mellitus despite early steroid discontinuation in hispanic kidney transplant recipients. Clin Transpl. 2005;19:4. PubMed

Shivaswamy V, Boerner B, Larsen J. Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr Rev. 2016;37:1. PubMed PMC

Ponticelli C, Glassock RJ. Prevention of complications from use of conventional immunosuppressants: a critical review. J Nephrol. 2019. 10.1007/s40620-019-00602-5. PubMed

Cole EH, Johnston O, Rose CL, Gill JS. Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin J Am Soc Nephrol. 2008. 10.2215/cjn.04681107. PubMed PMC

Matas AJ, Gillingham KJ, Humar A, Ibrahim HN, Payne WD, Gruessner RWG, Dunn TB, Sutherland DER, Najarian JS, Kandaswamy R. Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome. Transplantation. 2008;85:3. PubMed

Rekers NV, de Fijter JW, Claas FH, Eikmans M. Mechanisms and risk assessment of steroid resistance in acute kidney transplant rejection. Transpl Immunol. 2016. 10.1016/j.trim.2016.07.005. PubMed

Noto D, Barbagallo CM, Cascio AL, Cefalu’ AB, Cavera G, Caldarella R, Marino G, Travali S, Cutaia I, Maringhini S Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome. Kidney Int. 1999; 10.1046/j.1523-1755.1999.00489.x. PubMed

Moore RA, Callahan MF, Cody MF The effect of the American Heart Association Step One Diet on hyperlipidemia following renal transplantation. Transplantation. 1990; 10.1097/00007890-199001000-00013. PubMed

Cassader M, Ruiu G, Gambino R et al. Lipoprotein-apolipoprotein changes in renal transplant recipients: A 2-year follow-up. Metabolism. 1991; 10.1016/0026-0495(91)90067-7. PubMed

London GM, Asmar RG, O’Rourke MF, Safar ME, Investigators RP. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43:92–9. PubMed

Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B. Zanchetti A and group Vt. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022–31. PubMed

Manisty CH, Hughes AD. Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index. Br J Clin Pharmacol. 2013;75:79–92. PubMed PMC

Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005;366:1545–53. PubMed

D’Elia L, La Fata E, Iannuzzi A, Rubba PO. Effect of statin therapy on pulse wave velocity: a meta-analysis of randomized controlled trials. Clin Exp Hypertens. 2018;40(7):601–8. 10.1080/10641963.2017.1411498. PubMed